Prime Medicine, Inc. (PRME) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts PRME Hot Sheet
Join SI Premium – FREE
Prime Medicine, Inc. (NASDAQ: PRME) reported Q3 EPS of ($0.32), $0.11 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $1 million, versus $0 reported last year.
For earnings history and earnings-related data on Prime Medicine, Inc. (PRME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Prime Medicine (PRME) at Outperform
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- CoVolt Power files for proposed IPO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
